Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy

Journal of Neurology

Volumn 247, Issue 2, 2000, Pages 134-138

  Enting, R H ^a   Portegies, P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Anti HIV agents; Cytarabine; HIV infection; Progressive multifocal leukoencephalopathy

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; CYTARABINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETROSPECTIVE STUDY; SURVIVAL;

EID: 0034119736     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007794     Document Type: Article

References (22)

1. 1. Astrom KE, Mancall EL, Richardson EP (1958) Progressive multifocal leukoencephalopathy: a hitherto unrecognized complication of chronic leukaemia and Hodgkin's disease. Brain 81 : 93-111
2. 2. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ (1971) Cultivation of papova-like virus with progressive multifocal leukoencephalopathy. Lancet I: 1257-1260
3. 3. Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC (1991) Epidemiology of progressive multifocal leukoencephalopathy in the United States. Neurology 41:1733-1736
4. 4. Berger JR, Pall L, Lanska D, Whiteman M (1998) Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4:59-68
5. 5. Hall CD, Dafni U, Simpson D, et al (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy in patients with HIV infection. N Engl J Med 338:1345-1351
6. 6. Berger JR, Pall L, McArthur J, et al (1992) A pilot study of recombinant alpha 2a interferon in the treatment of AIDS-related progressive multifocal leukoencephalopathy. Neurology 42 [Suppl 3]:257
7. 7. Brosgart C, Roberts T, Safrin S, Marra CM, Colson N, Jaffe HS (1997) Cidofovir therapy for progressive multifocal leukoencephalopathy in two AIDS patients. In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Toronto, Canada [abstract I-5]
8. 8. Moreno S, Miralles P, Diaz MD, et al (1996) Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 23:1066-1068
9. 9. Albrecht H, Hoffmann C, Degen O, et al (1998) Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12:1149-1154
10. 10. Miralles P, Berenguer J, Garcia de Viedma D, et al (1998) Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12: 2467-2472
11. 11. Clifford DB, Yiannoutsos C, Glicksman M, et al (1999) HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52:623-625
12. 12. Castro KG, Ward JW, Slutsker L, et al (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41:1-13
13. 13. Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998) Predictive factors for prolonged survival in AIDS-associated progressive multifocal leukoencephalopathy. Ann Neurol 44:341-349
14. 14. Hansman-Whiteman ML, Donovan-Post J, Berger JR, Tate LG, Bell MD, Limonte LP (1993) Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 187:233-240
15. 15. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A (1997) Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 11:1-17
16. 16. Fong IW, Toma E, and the Canadian PML Study Group (1995) The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 20:1305-1310
17. 17. Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL (1999) JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 52:253-260
18. 18. Portegies P, Algra PR, Hollak CEM, et al (1991) Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 337: 680-681
19. 19. Nicoli F, Chave B, Peragut JC, Gastaut JL (1992) Efficacy of cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 339:306
20. 20. De Truchis P, Flament-Saillour M, Urtizberea JA, Hassine D, Clair B (1993) Inefficacy of cytarabine in progressive multifocal leukoencephalopathy. Lancet 342:622-623
21. 21. Huang SS, Skolasky RL, Dal Pan GJ, Royal WI, McArthur JC (1998) Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol 4:324-332
22. 22. De Luca A, Ammassari A, Cingolani A, Giancola ML, Antinori A (1998) Failure of HAART in AIDS-related progressive multifocal leukoencephalopathy. In: Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) San Francisco, USA [abstract I-273]